Pharma Journalist 9038 posts 0 comments

Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, announced a clinical trial collaboration agreement with Merck,…
Read More...

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a…
Read More...

Boehringer Ingelheim announced that the European Commission (EC) has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial…
Read More...

Orchard Therapeutics announced that the company has entered into two worldwide royalty-bearing license agreements with GlaxoSmithKline plc (GSK) for use of their proprietary lentiviral…
Read More...

SMi reports: Dr. Thakur Raghu Raj Singh from Queen’s University Belfast will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic…
Read More...

BioAegis Therapeutics Inc., announces that it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of…
Read More...

Novocure announced it has entered into a clinical trial collaboration agreement with MSD (a tradename of Merck & Co., Inc.), through a subsidiary, to develop Tumor Treating Fields…
Read More...

Sanofi and The University of Texas MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including…
Read More...

Fate Therapeutics, Inc. announced that the Company entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class…
Read More...

Medicago, a biopharmaceutical company headquartered in Quebec City, began Phase I clinical trials for its plant-derived COVID-19 vaccine candidate yesterday, administering the first…
Read More...